Torrent Pharmaceuticals (TORNTPHARM) — Corporate Action

Torrent Pharmaceuticals reported Q3 FY2026 consolidated revenue of ₹3,303 crores (up 18% YoY) with net profit of ₹635 crores (up 26% YoY). The Board declared an interim dividend of ₹29 per share (580% on face value). The company completed acquisition of 46.39% controlling stake in JB Chemicals & Pharmaceuticals on January 21, 2026, positioning itself as India's 5th largest pharma company. Operating EBITDA margin strengthened to 33%. International markets drove growth, with Brazil up 21% and US up 19% YoY.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this corporate action affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 13 February 2026?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 13 February 2026

TITAN Titan Company Limited Financial Results BHARTIARTL Bharti Airtel Limited Corporate Action BHARTIARTL Bharti Airtel Limited Financial Results COALINDIA Coal India Limited Financial Results GRASIM Grasim Industries Limited Financial Results HINDUNILVR Hindustan Unilever Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.